Digestive Diseases and Sciences

, Volume 37, Issue 7, pp 997–1001

Cisapride vs metoclopramide

An acute study in diabetic gastroparesis
  • S. McHugh
  • S. Lico
  • N. E. Diamant
Original Articles

Abstract

Radionuclide gastric solid-phase emptying was studied in 10 subjects with diabetic gastroparesis comparing the acute intravenous administration of cisapride (2.5, 5, 10 mg), placebo, and metoclopramide (10 mg). No hemodynamic or electrocardiographic changes were noted. While both cisapride and metoclopramide normalized impaired solid emptying, cisapride at its highest dosage (10 mg) resulted in significantly faster gastric emptying (P=0.003) than metoclopramide. The effects of cisapride were dose related and correlated well (r=0.48,P<0.01) with the plasma drug levels. Clinical studies of chronic oral usage must take into account the dose-related response and factors affecting blood levels.

Key Words

diabetic complications diabetic gastroparesis cisapride metoclopramide antral dysfunction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brown CK, Khanderia U: Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis. Clin Pharmacol 9:357–365, 1990Google Scholar
  2. 2.
    Snape WJ, Battle WM, Schwartz SS, Braunstein SN, Goldstein HA, Alavi A: Metoclopramide to treat gastroparesis due to diabetes mellitus. Ann Intern Med 96:444–446, 1982Google Scholar
  3. 3.
    Loo FD, Palmer DIO, Soergel KH, Kalbfleisch JH, Wood CM: Gastric emptying in patients with diabetic mellitus. Gastroenterology 7:25–32, 1985Google Scholar
  4. 5.
    Schade RR, Dugas MC, Lhotsky DM, Gavaler JS, Van Thiel DH: Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci 30:10–15, 1985Google Scholar
  5. 6.
    Feldman M, Smith HJ: Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticoum. A comparison with metoclopramide and placebo. Gastroenterology 92:171–174, 1987Google Scholar
  6. 7.
    Perkel MS, Moore C, Hersh T, Davidson ED: Metoclopramide therapy in patients with delayed gastric emptying. A randomized, double-blind study. Dig Dis Sci 24:662–666, 1975Google Scholar
  7. 8.
    Heer M, Muller-Duysing W, Benes I, Weitzel M, Pirovino M, Altorfer J, Schmid M: Diabetic gastroparesis: Treatment with domperidone—a double-blind, placebo-controlled trial. Digestion 27:214–217, 1983Google Scholar
  8. 9.
    Horowitz M, Harding PE, Chatterton BE, Collins PJ, Shearman DJC: Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 30:1–9, 1985Google Scholar
  9. 10.
    McCallum RW, Prakash C, Campoli-Richards DM, Goa KL: Cisapride. A preliminary review of its pharmacodynamic and pharmakokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal disorders. Drugs 36:652–681, 1988Google Scholar
  10. 11.
    Horowitz M, Maddox A, Harding PE, Maddern GH, Chatterton BE, Wishart J, Shearman JC: Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus. Gastroenterology 92:1899–1907, 1987Google Scholar
  11. 12.
    Horowitz M, Roberts AP: Long-term efficacy of cisapride in diabetic gastroparesis. Am J Med 88:195–196, 1990Google Scholar
  12. 13.
    Camilleri M, Malagalada J-R, Abell TL, Brown ML, Hench V, Zinsmeister AR: Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudo-obstruction. Gastroenterology 96:704–712, 1989Google Scholar
  13. 14.
    Champion MC: Management of idiopathic, diabetic and miscellaneous gastroparesis with cisapride. Scand J Gastroenterol 24(suppl 165):44–53, 1989Google Scholar
  14. 15.
    DeCaestecker JS, Ewing DJ, Tothill P, Clarke BF, Heading RC. Evaluation of oral cisapride and metoclopramide in diabetic autonomic neuropathy: An eight week double-blind crossover study. Aliment Pharmacol Ther 3:69–81, 1989Google Scholar
  15. 16.
    Havelund T, Oster-Jorgensen E, Eshoy O, Larsen ML, Lauritsen K: Effects of cisapride on gastroparesis in patients with insulin-dependent mellitus. A double-blind controlled trial. Acta Med Scand 222:339–343, 1987Google Scholar
  16. 17.
    Wright RA, Thompson D, Syed I: Simultaneous markers for fluid and solid gastric emptying: New variations on an old theme: Concise communication. J Nucl Med 22:772–776, 1981Google Scholar
  17. 18.
    Koch KL, Stern RM, Stewart WR, Varey MW: Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: Effect of long-term domperidone treatment. Am J Gastroenterol 84:1069–1075, 1989Google Scholar
  18. 19.
    Malagelada JR, Rees WDW, Mazzotta LF, Go VLW. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: Effect of metolopramide and bethanechol. Gastroenterology 78:286–293, 1980Google Scholar
  19. 20.
    Thom Forde GM, Zimmesita AR, Brown ML, Malagelada JR: Effects of cisapride and metoclopramide on fed gastrointestinal motility and transit in a chronic dog model. Gastroenterology 88:1613, 1985 (abstract)Google Scholar
  20. 21.
    Albibi R, McCallum R: Metoclopramide: Pharmacology and clinical application. Ann Intern Med 98:86–95, 1983Google Scholar

Copyright information

© Plenum Publishing Corporation 1992

Authors and Affiliations

  • S. McHugh
    • 1
  • S. Lico
    • 1
  • N. E. Diamant
    • 1
  1. 1.Division of Gastroenterology, Department of MedicineToronto Western HospitalTorontoCanada

Personalised recommendations